Gag-onc fusion protein

Source: Wikipedia, the free encyclopedia.

The gag-onc fusion protein

C-jun. (In the case of a fusion with C-jun, the resulting "gag-jun" protein is known alternatively as p65).[2]

Background

Gag genes are part of a general architecture for

reverse transcription, where the gag region of the genome encodes proteins that constitute the matrix, capsid and nucleocapsid of the mature virus particles. Like in HIV's replication cycle, these proteins are needed for viral budding from the host cell's plasma membrane, where the fully formed virions leave the cell to infect other cells.[3]

gag-v-onc

When a viral gene is introduced into the host cell and is sufficient to induce oncogenesis – the creation of cancerous cells – in the infected cell line, the gene is said to be a "viral transforming gene".[4] When this type of gene is translated to a protein, the protein is called a "transforming protein". Note that since the viral oncogenes originated from a host genome, the transformation event is different from transduction, which describes the process of introducing non-native genes to a host organism via a viral infection.

Rous sarcoma virus

The Gag-v-Onc fusion protein from the

oncogenesis becomes more likely for the infected host cells, since the v-Src gene is translated
into a functionally distinct version of its host counterpart.

murine leukemia virus

In the case of the

murines (mice), the viral life cycle can also be responsible for oncogenesis through a Gag-v-Onc fusion protein called "Mo-MuLV(src)", which is a Gag-v-Src protein capable of inducing oncogenesis in living mice.[7]

See also

References

  1. ^ .
  2. ^ "Oncogene Protein p65(gag-jun) - MeSH - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-07-11.
  3. ^ Principles of Virology, 3rd edition, Vol. 1, Molecular Biology, 2009
  4. .
  5. .
  6. .
  7. .